Skip to main content
. 2015 Oct 2;6(37):40247–40254. doi: 10.18632/oncotarget.5377

Figure 6. Schematic summarizing the major conclusion of the study.

Figure 6

We propose that ERβ functions as a gate-keeper of NF-κB activation by preventing the HIF-1-mediated activation of the IKKβ/pIκBα axis.